MacLaughlin DT - Search Results

1

Müllerian-inhibiting substance inhibits rat Leydig cell regeneration after ethylene dimethanesulphonate ablation.

Salva A, Hardy MP, Wu XF, Sottas CM, MacLaughlin DT, Donahoe PK, Lee MM. Salva A, et al. Among authors: maclaughlin dt. Biol Reprod. 2004 Mar;70(3):600-7. doi: 10.1095/biolreprod.103.021550. Epub 2003 Oct 29. Biol Reprod. 2004. PMID: 14585814

2

Müllerian inhibiting substance is present in embryonic testes of dogs with persistent müllerian duct syndrome.

Meyers-Wallen VN, Lee MM, Manganaro TF, Kuroda T, Maclaughlin D, Donahoe PK. Meyers-Wallen VN, et al. Biol Reprod. 1993 Jun;48(6):1410-8. doi: 10.1095/biolreprod48.6.1410. Biol Reprod. 1993. PMID: 8318594

3

Müllerian inhibiting substance inhibits testosterone synthesis in adult rats.

Sriraman V, Niu E, Matias JR, Donahoe PK, MacLaughlin DT, Hardy MP, Lee MM. Sriraman V, et al. Among authors: maclaughlin dt. J Androl. 2001 Sep-Oct;22(5):750-8. J Androl. 2001. PMID: 11545286 Free article.

4

Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism.

Misra M, MacLaughlin DT, Donahoe PK, Lee MM. Misra M, et al. Among authors: maclaughlin dt. J Clin Endocrinol Metab. 2002 Aug;87(8):3598-602. doi: 10.1210/jcem.87.8.8742. J Clin Endocrinol Metab. 2002. PMID: 12161481

5

Highly purified müllerian inhibiting substance inhibits human ovarian cancer in vivo.

Stephen AE, Pearsall LA, Christian BP, Donahoe PK, Vacanti JP, MacLaughlin DT. Stephen AE, et al. Among authors: maclaughlin dt. Clin Cancer Res. 2002 Aug;8(8):2640-6. Clin Cancer Res. 2002. PMID: 12171896

6

The role of Müllerian inhibiting substance in the evaluation of phenotypic female patients with mild degrees of virilization.

Misra M, MacLaughlin DT, Donahoe PK, Lee MM. Misra M, et al. Among authors: maclaughlin dt. J Clin Endocrinol Metab. 2003 Feb;88(2):787-92. doi: 10.1210/jc.2002-020889. J Clin Endocrinol Metab. 2003. PMID: 12574214

7

Mullerian inhibiting substance: an update.

MacLaughlin DT, Donahoe PK. MacLaughlin DT, et al. Adv Exp Med Biol. 2002;511:25-38; discussion 38-40. doi: 10.1007/978-1-4615-0621-8_3. Adv Exp Med Biol. 2002. PMID: 12575754 Review.

8

Müllerian inhibiting substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancers.

MacLaughlin DT, Donahoe PK. MacLaughlin DT, et al. Future Oncol. 2010 Mar;6(3):391-405. doi: 10.2217/fon.09.172. Future Oncol. 2010. PMID: 20222796 Free PMC article. Review.

9

Mullerian-inhibiting substance secretion is delayed in XX sex-reversed dog embryos.

Meyers-Wallen VN, MacLaughlin D, Palmer V, Donahoe PK. Meyers-Wallen VN, et al. Mol Reprod Dev. 1994 Sep;39(1):1-7. doi: 10.1002/mrd.1080390102. Mol Reprod Dev. 1994. PMID: 7999353

10

The critical period for mullerian duct regression in the dog embryo.

Meyers-Wallen VN, Manganaro TF, Kuroda T, Concannon PW, MacLaughlin DT, Donahoe PK. Meyers-Wallen VN, et al. Among authors: maclaughlin dt. Biol Reprod. 1991 Oct;45(4):626-33. doi: 10.1095/biolreprod45.4.626. Biol Reprod. 1991. PMID: 1751638

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters